$191 Million is the total value of Knoll Capital Management, LLC's 42 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Biohaven Pharmactl Hldg Co L | $83,182,000 | +42.0% | 856,844 | 0.0% | 43.44% | +13.8% | |
| APLT | Buy | Applied Therapeutics Inc | $21,448,000 | +11.6% | 1,032,123 | +0.6% | 11.20% | -10.6% |
| ENTX | Buy | Entera Bio Ltd | $14,856,000 | +117.7% | 2,484,275 | +38.7% | 7.76% | +74.5% |
| CRBP | Corbus Pharmaceuticals HLDGS | $9,234,000 | -7.1% | 5,045,870 | 0.0% | 4.82% | -25.5% | |
| ORGS | Orgenesis, Inc. | $6,674,000 | -11.5% | 1,316,364 | 0.0% | 3.48% | -29.1% | |
| ALDX | Aldeyra Therapeutics Inc | $6,451,000 | -4.6% | 569,405 | 0.0% | 3.37% | -23.6% | |
| EIGR | Eiger Biopharmaceuticals Inc | $5,915,000 | -3.7% | 694,232 | 0.0% | 3.09% | -22.8% | |
| Anavex Life Sciemves Corp | $4,819,000 | +52.9% | 210,789 | 0.0% | 2.52% | +22.6% | ||
| ABEO | Abeona Therapeutics Inc | $4,461,000 | -17.0% | 2,859,767 | 0.0% | 2.33% | -33.5% | |
| ANVS | New | Annovis | $3,356,000 | – | 39,210 | +100.0% | 1.75% | – |
| LUMN | Lumen Technologies Inc | $2,990,000 | +1.8% | 220,000 | 0.0% | 1.56% | -18.4% | |
| BX | Sell | Blackstone Group LP | $2,914,000 | -2.2% | 30,000 | -25.0% | 1.52% | -21.6% |
| XCUR | Exicure | $1,917,000 | -31.2% | 1,277,777 | 0.0% | 1.00% | -44.8% | |
| DOW | Dow Inc | $1,898,000 | -1.2% | 30,000 | 0.0% | 0.99% | -20.8% | |
| CTVA | Corteva Inc | $1,331,000 | -4.9% | 30,000 | 0.0% | 0.70% | -23.7% | |
| ANET | Arista Networks Inc | $1,250,000 | +20.1% | 3,450 | 0.0% | 0.65% | -3.7% | |
| CVS | CVS Health Corp | $1,210,000 | +10.9% | 14,500 | 0.0% | 0.63% | -11.1% | |
| DD | Dupont de Nemours Inc | $1,161,000 | +0.2% | 15,000 | 0.0% | 0.61% | -19.7% | |
| AMD | New | Advanced Micro Deviced Inc | $1,160,000 | – | 12,350 | +100.0% | 0.61% | – |
| V | Visa | $1,134,000 | +10.4% | 4,850 | 0.0% | 0.59% | -11.5% | |
| ALT | Altimmune Inc | $1,113,000 | +57.4% | 50,000 | 0.0% | 0.58% | +26.0% | |
| VMW | VMWare Inc | $1,112,000 | +6.3% | 6,950 | 0.0% | 0.58% | -14.7% | |
| BAH | Booz Allen Hamilton HLDG CORcl a | $1,107,000 | +5.7% | 13,000 | 0.0% | 0.58% | -15.2% | |
| GLW | Corning Inc | $1,088,000 | -6.0% | 26,600 | 0.0% | 0.57% | -24.7% | |
| MO | Altria Group Inc | $1,082,000 | -6.8% | 22,700 | 0.0% | 0.56% | -25.3% | |
| TMO | Thermo Fischer Scientific Inc | $1,059,000 | +10.5% | 2,100 | 0.0% | 0.55% | -11.4% | |
| SNGX | Soligenix Inc. | $874,000 | -27.5% | 787,830 | 0.0% | 0.46% | -41.9% | |
| ANGN | Angion BioMedica Corp | $781,000 | -28.0% | 60,000 | 0.0% | 0.41% | -42.2% | |
| MMX | MAVERIX METALS INC | $620,000 | +2.3% | 115,000 | 0.0% | 0.32% | -18.0% | |
| BTAI | BioXCel Therapeutics Inc | $581,000 | -32.7% | 20,000 | 0.0% | 0.30% | -46.1% | |
| SA | SEABRIDGE GOLD INC | $562,000 | +8.7% | 32,000 | 0.0% | 0.29% | -13.1% | |
| FNV | FRANCO NEV CORP | $544,000 | +15.7% | 3,750 | 0.0% | 0.28% | -7.2% | |
| OR | OSISKO GOLD ROYALTIES LTD | $474,000 | +5.8% | 190,000 | 0.0% | 0.25% | -15.1% | |
| AEM | AGNICO EAGLE MINES LTD | $417,000 | +4.5% | 6,900 | 0.0% | 0.22% | -16.2% | |
| KL | KIRKLAND LAKE GOLD LTD | $414,000 | +14.0% | 10,750 | 0.0% | 0.22% | -8.5% | |
| AGTC | New | Applied genetiv therapies | $391,000 | – | 100,000 | +100.0% | 0.20% | – |
| SVM | Buy | SILVERCORP METALS INC | $384,000 | +114.5% | 70,000 | +91.8% | 0.20% | +71.8% |
| SILV | Buy | SILVERCREST METALS INC | $367,000 | +46.8% | 42,000 | +35.5% | 0.19% | +17.8% |
| MAG | MAG SILVER CORP | $362,000 | +39.2% | 17,300 | 0.0% | 0.19% | +11.8% | |
| EQX | EQUINOX GOLD CORP | $316,000 | -13.2% | 45,500 | 0.0% | 0.16% | -30.4% | |
| FSM | FORTUNA SILVER MINES INC | $253,000 | -10.6% | 43,700 | 0.0% | 0.13% | -28.3% | |
| PAAS | PAN AMERN SILVER CORP | $234,000 | -4.9% | 8,200 | 0.0% | 0.12% | -23.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Aldeyra Therapeutics Inc | 35 | Q3 2023 | 31.6% |
| Corbus Pharmaceuticals HLDGS | 30 | Q3 2022 | 46.5% |
| Abeona Therapeutics Inc | 30 | Q3 2022 | 34.8% |
| Biohaven Pharmactl Hldg Co L | 26 | Q3 2023 | 79.6% |
| Entera Bio Ltd | 22 | Q3 2023 | 7.8% |
| Ampio Pharmaceuticals Inc. | 21 | Q2 2018 | 11.0% |
| Soligenix Inc. | 20 | Q3 2022 | 1.7% |
| Eiger Biopharmaceuticals Inc | 19 | Q3 2022 | 5.8% |
| Applied Therapeutics Inc | 18 | Q3 2023 | 19.7% |
| Alcobra Ltd | 18 | Q3 2017 | 6.5% |
View Knoll Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HOOKIPA Pharma Inc. | June 20, 2023 | 5,517,385 | 6.8% |
| Applied Therapeutics Inc. | January 23, 2023 | 3,450,000 | 7.2% |
| Orgenesis Inc. | August 14, 2020 | 1,316,364 | 5.9% |
| Corbus Pharmaceuticals Holdings, Inc. | February 14, 2020 | 5,045,870 | 7.1% |
| ABEONA THERAPEUTICS INC. | February 14, 2018 | 2,359,767 | 5.0% |
| SOLIGENIX, INC. | November 13, 2017 | 870,000 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2017 | 2,359,767 | 5.9% |
| ALCOBRA LTD. | February 14, 2017 | 1,205,498 | 4.4% |
| Ampio Pharmaceuticals, Inc. | February 14, 2017 | 2,738,322 | 4.8% |
| RITTER PHARMACEUTICALS INC | February 14, 2017 | 952,434 | 8.2% |
View Knoll Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-04 |
| 13F-HR | 2023-08-15 |
| SC 13G | 2023-06-20 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
View Knoll Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.